Company Filing History:
2 out of 164 
2 out of 38 
2 out of 4,554 
Years Active: 2003-2022
Title: Innovations of Zijian Guo in Engineered Polypeptides
Introduction
Zijian Guo is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of engineered polypeptides. With a total of six patents to his name, Guo has focused on developing compounds that enhance the duration of action and reduce immunogenicity in therapeutic applications. His work has the potential to address various diseases and disorders, making a substantial impact in the pharmaceutical industry.
Latest Patents
Guo's latest patents include innovative engineered polypeptides that offer enhanced duration of action. These compounds are designed to provide high potency and convenient dosing regimens, including once-weekly administration. The engineered polypeptides incorporate an albumin binding domain along with one or more biologically active polypeptides. The pharmaceutical compositions and methods of treatment developed by Guo target a range of diseases and disorders, including lipodystrophy, dyslipidemia, hyperlipidemia, obesity, Alzheimer's disease, and diabetes, among others. Additionally, his work addresses conditions such as nonalcoholic steatohepatitis (NASH) and metabolic syndrome X.
Career Highlights
Throughout his career, Zijian Guo has worked with notable companies in the pharmaceutical sector, including Amylin Pharmaceuticals and AstraZeneca Pharmaceuticals. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions. Guo's dedication to research and development has positioned him as a key figure in the advancement of engineered polypeptides.
Collaborations
Guo has collaborated with esteemed colleagues, including Mary Erickson and David C. Litzinger. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the field.
Conclusion
Zijian Guo's work in engineered polypeptides exemplifies the intersection of innovation and therapeutic advancement. His contributions have the potential to transform treatment options for various diseases, showcasing the importance of research and development in the pharmaceutical industry.